AzTrials
AzTrials

Willingness to ParticipateNCT06862999

Willingness to Participate in a Daily Smartphone Well-being Study

A study testing No Incentive Email, Financial Incentive Email and Social Incentive Email in people with Willingness to Participate, run by University of Manchester at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical trial aims to compare the effectiveness of financial and social incentives in motivating urban populations to participate in Experience Sampling Method (ESM) wellbeing studies and explore alternative incentive preferences to increase participation. Read more about this study

Who is it for?
Any age
Conditions the study is for
Willingness to Participate
What is being tested?
No Incentive Email, Financial Incentive Email and Social Incentive Email
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
324 participants
Where
1 siteUnited Kingdom
Study dates
12 Sep 2024to 30 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Registered on the King's Cross community smartphone application.
  • App users living, working, or have previously visited King\'s Cross
  • Given consent to receive email communications during their smartphone app sign-up.

Who cannot join

  • Users of the King's Cross community smartphone app who have not given consent to receive email communication about the neighbourhood

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Related Argent

    London, Greater London, N1C 4AB

Other trials in United Kingdom

About this study

Official title: Comparing the Effectiveness of Non-financial Incentive to Participate in a Smartphone Experience Sampling Method Well-being Study: Protocol for a Randomised Controlled Trial

This clinical trial aims to compare the effectiveness of financial and social incentives in motivating urban populations to participate in Experience Sampling Method (ESM) wellbeing studies and explore alternative incentive preferences to increase participation.

Read the detailed description

The goal of this clinical trial is to investigate the comparison of two incentives to determine their effectiveness for motivating an urban population to participate in a Experience Sampling Method wellbeing studies. It will also investigate alternative incentive preferences that can motivate the population. The main questions it aims to answer are:

  • Does the provision of a financial incentive or social incentive to neighbourhood research participants increase the willingness of individuals to participate in ESM research compared to offering no incentive?
  • What are the reasons for unwillingness to participate in ESM studies?
  • What are the alternative incentive preference that could increase willingness to participate in ESM studies?

Researchers will compare monetary incentive (4 x £100 prize draw qualification) to a non-monetary incentive (invitation to end of project social event to engage research findings) to how they influence willingness to participate compared to offering no incentive.

Participants will:

  • Receive receive an email describing a future experience sampling study in the neighbourhood for at least two times.
  • Complete a survey to indicate their positive or negative interest in the hypothetical study.
Being tested
No Incentive Email, Financial Incentive Email, Social Incentive Email
Keywords
Experience Sampling Method, Willingness to Participate, Neighbourhood studies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No Incentive EmailBehavioural

    Participant will receive an email describing a hypothetical experience sampling study that will happen in King's Cross where he or she is an inhabitant as a worker, resident, or visitor. However, this email will not include any promised compensation for future participation in the hypothetical wellbeing study in the neighbourhood. This group serves as the control group to compare the effects of incentives on participation rates.

  • Financial Incentive EmailBehavioural

    Participant will receive an email describing a hypothetical experience sampling study that will happen in King\'s Cross where he or she is an inhabitant as a worker, resident, or visitor. This email will include a paragraph that describes a compensation for participation in the future study. The type of compensation that will be offered is a financial compensation, which is a chance of enter a prize draw to win a 4 X £100 voucher which can be used to purchase goods and services within the King\'s Cross neighbourhood in London.

  • Social Incentive EmailBehavioural

    Participant will receive an email describing a hypothetical experience sampling study that will happen in King\'s Cross where he or she is an inhabitant as a worker, resident, or visitor. This email will include a paragraph that describes a compensation for participation in the future study. The type of compensation that will be offered is a non-financial compensation, which is an invitation to participate in a social event that will be organised by the researchers and the neighbourhood asset manager team at the end of the research project. This event will be exclusive and it will be an opportunity for participants to socialize with other study participants in the neighbourhood. It will also be an opportunity for the study participants to feel they are contributing a change to the neighbourhood and will be able to articulate their views about the wellbeing research findings which is expected to be used to inform future interventions in the neighbourhood.

Study groups in NCT06862999
Study groupRoleWhat they receive
Control GroupPlacebo comparatorParticipants in this group will receive no incentive for participating in the future experience sampling study.
Receives: Behavioral: No Incentive Email
Financial Incentive GroupExperimentalParticipants in this group will receive a financial incentive for participating in the future experience sampling study.
Receives: Behavioral: Financial Incentive Email
Non-Financial Incentive GroupExperimentalParticipants in this group will receive a non-financial incentive for participating in the future experience sampling study.
Receives: Behavioral: Social Incentive Email

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Willingness to participate

    Measure the proportion of participants in each arm who agree to participate in the experience sampling study.

    Measured: From enrollment to the end of treatment at 7 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2025
  2. Study start12 Sep 2024
  3. Primary completion30 Nov 2024
  4. Study completion30 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
324 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06862999
Sponsor's protocol ID
2023-17042-30162
Other IDs
2023
Status last verified
Mar 2025
First submitted
5 Mar 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: With the exception of the identifying email addresses, the demographic and outcome data that was collected from the participant will be publicly made available on UK Data Service ReShare, a platform for archiving research data.

Questions about this trial

What is this clinical trial studying?

A study testing No Incentive Email, Financial Incentive Email and Social Incentive Email in people with Willingness to Participate, run by University of Manchester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Willingness to participate (time frame: From enrollment to the end of treatment at 7 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in